— § 02
What the literature shows.
Skin endpoints (direct)
—
No defensible RCTs on spirulina for skin in humans. Allergic / atopic claims are mechanistic rather than trial-supported.
15%
Allergic rhinitis
Small RCTs
Modest, replicated effect on allergic rhinitis symptoms. Indirect skin connection only via atopic comorbidity.
55%
General antioxidant capacity (biomarkers)
Mixed
Real biomarker shifts; whether these translate to skin endpoints is unestablished.
50%
Heavy metal / microcystin contamination
Surveillance
Unregulated spirulina from open-water farms can contain microcystins (hepatotoxins) and heavy metals. Source and certification matter.
Caution